| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2006 | EP1675954A1 Nucleic acids useful for triggering tumor cell lethality |
| 07/05/2006 | EP1675951A2 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 07/05/2006 | EP1675948A2 RNA INTERFERENCE MEDIATED TREATMENT OF PARKINSON DISEASE USING SHORT INTERERING NUCLEIC ACID (siNA) |
| 07/05/2006 | EP1675891A1 Pectin films prepared from gamma irradiated pectin |
| 07/05/2006 | EP1675866A1 Novel triterpene derivatives, preparation thereof and use thereof |
| 07/05/2006 | EP1675863A2 Method for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
| 07/05/2006 | EP1675861A1 Pyrimidothiophene compounds |
| 07/05/2006 | EP1675860A2 Imidazo[1,5-a]pyrazine tyrosine kinase inhibitors |
| 07/05/2006 | EP1675858A2 5-aryl-pyrazolo [4,3-d] pyrimidines, pyridines, and pyrazines and related compounds |
| 07/05/2006 | EP1675855A1 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity |
| 07/05/2006 | EP1675852A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/05/2006 | EP1675850A1 Quinoline compounds and their uses |
| 07/05/2006 | EP1675848A1 Novel triarylimidazoles |
| 07/05/2006 | EP1675847A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 07/05/2006 | EP1675846A1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h- [1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone |
| 07/05/2006 | EP1675845A2 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
| 07/05/2006 | EP1675841A1 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid |
| 07/05/2006 | EP1675837A2 Benzo [1,2,5] thiadiazole compounds as cck2 modulators |
| 07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 07/05/2006 | EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 07/05/2006 | EP1675834A1 Compounds, compositions, and methods |
| 07/05/2006 | EP1675833A1 1h-imidazole derivatives as cannabinoid receptor modulators |
| 07/05/2006 | EP1675829A1 Preparation of 3-azabicyclo [3.1.0] hexane derivatives |
| 07/05/2006 | EP1675824A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists |
| 07/05/2006 | EP1675821A1 Phenetanolamine derivatives |
| 07/05/2006 | EP1675820A2 Propionic acid derivatives useful in the treatment of lipid disorders |
| 07/05/2006 | EP1675817A1 Aminoalkanol derivatives |
| 07/05/2006 | EP1675652A2 Treatment of ocular disease |
| 07/05/2006 | EP1675651A1 Composition and dosage form for sustained effect of levodopa |
| 07/05/2006 | EP1675625A1 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 07/05/2006 | EP1675622A2 Multi-arm polymer prodrugs |
| 07/05/2006 | EP1675621A2 Pharmaceutical compositions of lavendustin |
| 07/05/2006 | EP1675619A1 Sustained release l-arginine formulations and methods of manufacture and use |
| 07/05/2006 | EP1675614A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 07/05/2006 | EP1675596A2 Method |
| 07/05/2006 | EP1675595A2 Immunemodulating oligosaccharides |
| 07/05/2006 | EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/05/2006 | EP1675593A1 Process for making sterile aripiprazole of desired mean particle size |
| 07/05/2006 | EP1675592A1 Improved antitumoral combinations containing et-743 and a cruciferous indole compound |
| 07/05/2006 | EP1675591A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor |
| 07/05/2006 | EP1675590A1 The use of ifenprodil in the treatment of pain |
| 07/05/2006 | EP1675589A2 Treatment of inflamed joints |
| 07/05/2006 | EP1675586A1 Methods for treating non-microbial inflammatory skin conditions |
| 07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
| 07/05/2006 | EP1675583A1 Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof |
| 07/05/2006 | EP1675582A1 Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders |
| 07/05/2006 | EP1675581A1 TREATMENT OF GASTROPARESIS AND NONULCER DYSPEPSIA WITH GABA-b AGONISTS |
| 07/05/2006 | EP1675580A1 Natural menaquinone 7 compositions |
| 07/05/2006 | EP1675578A2 Use of effectors of glutaminyl and glutamate cyclases |
| 07/05/2006 | EP1675575A2 Extended release pharmaceutical dosage form |
| 07/05/2006 | EP1675574A2 Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation |
| 07/05/2006 | EP1675573A2 Controlled release sterile injectable aripiprazole formulation and method |
| 07/05/2006 | EP1675572A2 Coated metal pyrithione particles for treatment of microorganisms |
| 07/05/2006 | EP1675570A2 Use of photodynamic therapeutic agents entrapped in ceramic nanoparticles |
| 07/05/2006 | EP1675569A1 Delivery of therapeutic compounds via microparticles or microbubbles |
| 07/05/2006 | EP1675568A1 Buccal, polar and non-polar spray containing zolpidem |
| 07/05/2006 | EP1675567A1 Buccal, polar and non-polar spray containing sumatriptan |
| 07/05/2006 | EP1675566A1 Buccal, polar and non-polar spray containing diazepam |
| 07/05/2006 | EP1675558A1 Cosmetic composition comprising a tensioning agent and a particular block ethylenic polymer |
| 07/05/2006 | EP1675557A1 Composition comprising a sesquiterpene lactone |
| 07/05/2006 | EP1675552A2 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 07/05/2006 | EP1675550A2 Therapeutic regimens for administering drug combinations |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1675540A1 Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide |
| 07/05/2006 | EP1675481A2 Synbiotic composition for infants |
| 07/05/2006 | EP1675465A2 Improved combination bacteriolytic therapy for the treatment of tumors |
| 07/05/2006 | EP1675463A2 Anhydrous silver dihydrogen citrate compositions |
| 07/05/2006 | EP1675460A2 Performance aid for pesticide or repellent compositions |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1631155A4 Method for producing a chitosan containing salt having a function of lowering blood pressure |
| 07/05/2006 | EP1490360A4 Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 07/05/2006 | EP1467744A4 Aqueous compositions containing metronidazole |
| 07/05/2006 | EP1401440A4 Methods of use of fluoroquinolone compounds against bacteria |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1389044A4 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| 07/05/2006 | EP1385844B1 Oxazolidinones containing a sulfonimid group as antibiotics |
| 07/05/2006 | EP1385505B1 Acne treatment with lipooxigenase inhibitors |
| 07/05/2006 | EP1377575B1 Antiviral pyrazolopyridine compounds |
| 07/05/2006 | EP1368040B1 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/05/2006 | EP1326644B1 Absorption enhancers |
| 07/05/2006 | EP1313762B1 Suppressor gene |
| 07/05/2006 | EP1313739B1 Alkylated imidazopyridine derivatives |
| 07/05/2006 | EP1259241B1 The use of scopolamine salts |
| 07/05/2006 | EP1259240B1 Agents, such as nicotinamide or cadpr for the treatment of skin disorders |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | EP1248626B1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/05/2006 | EP1242084B1 Treatment of breast carcinomas, astrocytomas, melanomas and related tumors |
| 07/05/2006 | EP1235900B1 Microparticle-based transfection and activation of dendritic cells |
| 07/05/2006 | EP1234582B1 Concomitant drugs for treating glaucoma |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1196559B1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/05/2006 | EP1183026B1 Improved pharmaceutical formulations comprising ritonavir |
| 07/05/2006 | EP1141318B1 P450 / acetaminophen gdept for cancer treatment |
| 07/05/2006 | EP1139755B9 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 07/05/2006 | EP1113797A4 Treatment of persistent pain |
| 07/05/2006 | EP1106175B1 Anti-inflammatory ascorbic acid derivatives |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | EP1095042B9 Antiparasitic artemisinin derivatives (endoperoxides) |
| 07/05/2006 | EP1067958B1 Treatment of cardiac hypertrophy |
| 07/05/2006 | EP1044005B1 1,2,4-benzotriazine oxides formulations |